New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
06:14 EDTBLFSBioLife Solutions CryoStor demonstrates superior cell preservation in study
BioLife Solutions announced that the company's CryoStor clinical grade cell freeze media was evaluated in a multicenter biobanking study of various shipment conditions for cells used to support proficiency testing programs. The study compared preservation media The study authors' conclusions include: CryoStor CS10/Dry Ice combination gives higher viability by every method, for each viability level, and is the most cost-efficient shipment method. Liquid nitrogen shipments are impractical. In these cases, we show that alternatively high quality shipment conditions for viable cells are dry ice shipment and CryoStor CS10 cryopreservation medium. For both Jurkat and peripheral blood mononuclear cells, it is possible to use CryoStor CS10 with dry ice shipment or when the initial cell suspension displays suboptimal viability, without dramatic impact on cell viability. Room temperature transport medium dramatically and adversely affected the integrity of mononuclear cells.
News For BLFS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
06:08 EDTBLFSBioLife Solutions, Capricor provide update on CAP-1002 DYNAMIC clinical trial
Subscribe for More Information
November 12, 2015
16:25 EDTBLFSBioLife Solutions sees FY15 biopreservation media product revenue up 20%-30%
Subscribe for More Information
16:25 EDTBLFSBioLife Solutions reports Q3 EPS (9c), one estimate (10c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use